PPD, Inc. plans to expand its global central lab services into Singapore in response to growing demand in Southeast Asia. The lab is expected to begin operations in mid-2009 and will provide biopharmaceutical clients with a “comprehensive range of highly customized lab services,” according to a PPD statement. “Southeast Asia is an attractive region for conducting clinical trials, and Singapore is an important biopharmaceutical hub,” said Agostino L. Fede, Ph.D., senior...